Enhabit, Inc. (NYSE:EHAB) Sees Significant Decrease in Short Interest

Enhabit, Inc. (NYSE:EHAB) saw a large decline in short interest in October. As of October 31st, there was short interest totalling 1,340,000 shares, a decline of 20.2% from the October 15th total of 1,680,000 shares. Based on an average daily volume of 624,400 shares, the short-interest ratio is presently 2.1 days. Approximately 3.1% of the company’s stock are sold short.

Insider Buying and Selling

In other Enhabit news, Director Jeffrey Bolton bought 5,000 shares of the firm’s stock in a transaction on Thursday, August 22nd. The stock was acquired at an average price of $8.01 per share, with a total value of $40,050.00. Following the transaction, the director now owns 78,877 shares in the company, valued at $631,804.77. This represents a 6.77 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 1.90% of the stock is currently owned by company insiders.

Institutional Trading of Enhabit

Hedge funds and other institutional investors have recently bought and sold shares of the stock. AREX Capital Management LP increased its holdings in Enhabit by 2.5% in the 2nd quarter. AREX Capital Management LP now owns 2,472,662 shares of the company’s stock worth $22,056,000 after acquiring an additional 59,353 shares in the last quarter. Systematic Financial Management LP raised its holdings in Enhabit by 12.2% during the third quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock valued at $14,522,000 after acquiring an additional 199,235 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of Enhabit by 1.5% in the second quarter. Dimensional Fund Advisors LP now owns 1,756,745 shares of the company’s stock valued at $15,669,000 after acquiring an additional 26,753 shares in the last quarter. Paradice Investment Management LLC grew its position in shares of Enhabit by 0.7% during the second quarter. Paradice Investment Management LLC now owns 1,525,037 shares of the company’s stock worth $13,603,000 after purchasing an additional 11,128 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale raised its stake in Enhabit by 52.3% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 518,412 shares of the company’s stock valued at $4,306,000 after purchasing an additional 178,000 shares during the period.

Enhabit Stock Performance

NYSE:EHAB traded down $0.09 during mid-day trading on Friday, reaching $7.35. The company’s stock had a trading volume of 419,503 shares, compared to its average volume of 583,356. Enhabit has a 12-month low of $6.85 and a 12-month high of $11.74. The firm’s fifty day moving average price is $7.58 and its two-hundred day moving average price is $8.52. The company has a current ratio of 1.46, a quick ratio of 1.48 and a debt-to-equity ratio of 0.85. The stock has a market cap of $369.59 million, a P/E ratio of -3.13 and a beta of 1.84.

Enhabit (NYSE:EHAB) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.01). The business had revenue of $253.60 million for the quarter, compared to analysts’ expectations of $261.69 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. During the same quarter in the prior year, the business earned $0.03 EPS. On average, equities analysts forecast that Enhabit will post 0.25 EPS for the current fiscal year.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.